PATENT CLAIM ANALYSIS

Application Number: 16412804
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-08
Patent Classification: ["514", "561000"]

Abstract:
The present disclosure provides co-crystals of a substituted glycine compound and a co-former compound of Formula (I): compositions comprising such, and uses thereof in treating and/or reducing the risk for a neuropsychiatric disorder (e.g., schizophrenia, psychotic disorders, depressive disorders, suicidal ideation and/or behavior, obsessive compulsive disorder or Alzheimer's disease). Also provided herein are methods for preparing the co-crystals.

Claim (Index 30):
A co-crystal comprising N-trimethylglycine and a co-former, wherein the co-former is a compound of Formula (IB): in which:\n A and B are both H or both OH; \n W is O; \n X is H; \n Z is OH; \n C 2 C 1  are C 2 \u2550C 1  or C 2 -C 1 ; and \n wherein the molecular ratio between the N-trimethylglycine and the co-former in the co-crystal ranges from 2:1 to 1:1.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 100.0
- Lexical Diversity: 1.35849
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15944722', '15866303', '15430750', '16130836', '15188545']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7513326431314368
- 35 USC 102 Novelty (BERT): 0.5721325081041125
- Combined Prediction Score: 0.7334126296287043
- Mean Citation Score: 386.35124400000007
- Max Citation Score: 461.1239
- Similarity Product: 378.37640930731294

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test